Quoin Pharmaceuticals, Ltd. (QNRX)

Quoin Pharmaceuticals Statistics

Total Valuation

QNRX has a market cap or net worth of $2.87 million. The enterprise value is -$4.36 million.

Market Cap	2.87M
Enterprise Value	-4.36M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

QNRX has 5.05 million shares outstanding. The number of shares has increased by 336.80% in one year.

Current Share Class	n/a
Shares Outstanding	5.05M
Shares Change (YoY)	+336.80%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.45%
Owned by Institutions (%)	3.27%
Float	4.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.53
P/TBV Ratio	0.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.02, with a Debt / Equity ratio of 0.56.

Current Ratio	3.02
Quick Ratio	2.97
Debt / Equity	0.56
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -135.37% and return on invested capital (ROIC) is -59.56%.

Return on Equity (ROE)	-135.37%
Return on Assets (ROA)	-44.13%
Return on Capital (ROIC)	-59.56%
Revenue Per Employee	n/a
Profits Per Employee	-$2.18M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.88% in the last 52 weeks. The beta is 1.81, so QNRX's price volatility has been higher than the market average.

Beta (5Y)	1.81
52-Week Price Change	-85.88%
50-Day Moving Average	0.69
200-Day Moving Average	0.69
Relative Strength Index (RSI)	41.40
Average Volume (20 Days)	3,351,138

Short Selling Information

Short Interest	95,148
Short Previous Month	274,488
Short % of Shares Out	1.88%
Short % of Float	1.93%
Short Ratio (days to cover)	0.20

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.34M
Pretax Income	-8.28M
Net Income	-8.70M
EBITDA	-9.24M
EBIT	-9.34M
Earnings Per Share (EPS)	-$2.64

Balance Sheet

The company has $10.31 million in cash and $3.07 million in debt, giving a net cash position of $7.23 million or $1.43 per share.

Cash & Cash Equivalents	10.31M
Total Debt	3.07M
Net Cash	7.23M
Net Cash Per Share	$1.43
Equity (Book Value)	5.44M
Book Value Per Share	1.08
Working Capital	7.02M

Cash Flow

Operating Cash Flow	-8.84M
Capital Expenditures	n/a
Free Cash Flow	-8.84M
FCF Per Share	-$1.75

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

QNRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-336.80%
Shareholder Yield	-336.80%
Earnings Yield	-302.83%
FCF Yield	-307.82%

Analyst Forecast

The average price target for QNRX is $4.00, which is 602.99% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.00
Price Target Difference	602.99%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on July 18, 2023. It was a reverse split with a ratio of 0.0833333:1.

Last Split Date	Jul 18, 2023
Split Type	Reverse
Split Ratio	0.0833333:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1